Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2020-08, Vol.34 (8), p.2271-2275
Hauptverfasser:	Burke, G. A. Amos, Beishuizen, Auke, Bhojwani, Deepa, Burkhardt, Birgit, Minard-Colin, Véronique, Norris, Robin E., Kabickova, Edita, Pinarli, F. Guclu, Tacyildiz, Nurdan, Howes, Angela, Jong, Jan de, Liu, Grace, Nottage, Kerri, Salman, Mariya, Trixhe, Xavier Woot de, Cairo, Mitchell
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/153 692/699/67/1990/291/1621/1915 Adenine - analogs & derivatives Adolescent Cancer Research Carboplatin Child Child, Preschool Children Combined Modality Therapy Correspondence Critical Care Medicine Diseases Female Hematology Humans Immunotherapy Intensive Internal Medicine Lymphoma, B-Cell - mortality Lymphoma, B-Cell - therapy Male Medical colleges Medicine Medicine & Public Health Oncology Palliative treatment Pharmacokinetics Piperidines Pyrazoles - adverse effects Pyrazoles - pharmacokinetics Pyrazoles - therapeutic use Pyrimidines - adverse effects Pyrimidines - pharmacokinetics Pyrimidines - therapeutic use Vincristine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!